Results 231 to 240 of about 162,133 (299)

Inhibition of Endothelial Phosphodiesterase 2A Attenuates Post-infarct Inflammation. [PDF]

JACC Basic Transl Sci
Wagde VV, Liu Z, Schlemper A, Bartolomaeus H, Potapenko T, Krebes L, Dabral S, Rizakou A, Sheta D, Monterisi S, Ramos G, Zernecke A, Zaccolo M, Kuhn M, Werner F.   +14 more
europepmc   +1 more source

The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK-p65 NF-κB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression. [PDF]

J Biol Chem
Pimentel JM, Bosompra O, Trejo J.
europepmc   +1 more source

A combined endovascular and ultrasound approach to femoral artery pseudoaneurysm injection following transcatheter aortic valve replacement (TAVR). [PDF]

Radiol Case Rep
Sehgal VS, Menon A, Schor J, Singh K.
europepmc   +1 more source

Divergent molecular strategies of next-generation activated factor VIII mimetics: insights from a direct comparative analysis. [PDF]

Res Pract Thromb Haemost
Matsushita T.
europepmc   +1 more source

THE ACETYLATION OF THROMBIN

Canadian Journal of Biochemistry and Physiology, 1959
Purified thrombin-C loses its clotting power upon acetylation. The thrombin-E which is produced during the acetylation has approximately twice the proteolytic activity as the original thrombin-C. Evidently amino groups are not necessary to have thrombin-E activity, but if o-acyl groups are also produced the enzyme does not hydrolyze p ...
R H, LANDABURU, W H, SEEGERS
openaire   +3 more sources

Thrombin and acetylated thrombin in the activation of fibrinolysis

Canadian Journal of Physiology and Pharmacology, 1968
Thrombin that has been acetylated on its free amino group loses its fibrinogen-clotting properties, but when injected intravenously produces a fibrinolytic syndrome. The lytic results compare very closely to those obtained with thrombin administration, but acetylated thrombin does not produce fibrin deposition.
R H, Landaburu, E, Giavedoni, R, Santillán   +2 more
openaire   +3 more sources